Skip to content Skip to footer


The fundamental B2B building blocks that companies need to succeed in the cannabis industry.


Our influential series of B2B conferences and expos bridge the gap between cannabis and the mainstream. They provide the platform for cannabis businesses, brands, investors and policymakers to connect, get deals done and build ongoing commercial relationships. These pivotal events are attended by thousands of delegates from over 50 countries annually.


Our reliable and credible data on commercial opportunities, market size and the regulatory environment in key cannabis markets globally provides our 300,000 monthly readers with actionable business insights. This global community also trusts our respected range of digital media titles to keep them informed on the latest industry developments through a variety of multimedia content.


Through technology, we’re removing many of the barriers preventing exponential growth for Europe’s cannabis industry and the businesses that operate within it. We’re powering cannabis commerce by providing a trusted space where buyers can make safe and informed purchases, and sellers can distinguish and grow their business. A space where product quality is obvious and payments are painless.

Data &

B2B Cannabis Technology

Media &

Events &

About Us

Prohibition Partners is the discovery platform for B2B cannabis with fully integrated solutions across conferences, content and commerce. The company was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world.

Our Brands

Our portfolio includes some of the most widely used and respected brands in the global cannabis industry.


Website Product Images_Cover_new
The Pharmaceutical Cannabis Report: 3rd Edition
Co-authored in collaboration with Cannabiscientia, this report gives a clear and detailed account of all activity involving cannabis and cannabinoids in the landscape of pharmaceutical medicine, at a global level. The main topics covered include an analysis of the re...
photo_2023-04-11 11.14.39
The European Adult-Use Cannabis Report
A 70+ page report on adult-use markets in Europe is available to purchase, focusing on developments in Germany, Czech Republic, Switzerland and the Netherlands. This package also includes adult-use market sizing forecasts (2023-2027).
The European Cannabis Report: 8th Edition
The European Cannabis Report: 8th Edition, 2023 provides the latest information and analysis on the development of the cannabis markets across Europe. Included in the report are deep dives into all key sectors and geographic regions in the European cannabis industry,...
The European CBD Report: Health & Wellness
Specific laws and regulations for CBD are lagging far behind the evolution of the market, meaning CBD is now potentially the largest CPG product in Europe which is, in the majority, sold under legally ‘grey’ conditions. This situation is evolving fast, with new laws,...
African Cannabis Market Overview
The African medical cannabis and industrial hemp industries have seen significant growth and development over the course of 2021 and 2022. Countries such as South Africa, Lesotho, Zimbabwe, Uganda and Malawi have seen an increase in licence issuance, exports and inv...
cover-square 2 (1)
The Global Cannabis Report: 3rd Edition
Prohibition Partners estimates that, in 2022, the global sales of CBD, medical and adult-use cannabis amounted to US$45 billion and could be worth more than US$101 billion by 2026. Cannabis liberalisation is accelerating, with an increasing number of States and...

Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe

Co-authored by Prohibition Partners and Cannabiscientia SA,  this publication is intended to be of support to European healthcare professionals, and all those interested in understanding the medical use of cannabis in Europe. In a single eBook, it provides a comprehensive overview of the science, regulations, medicine and products on the market.

Topics covered include the physiology of the endocannabinoid system, the pharmacology of cannabis and its clinical relevance for a number of pathologies. The Handbook also includes case studies and practical evidence of experienced prescribers around the globe that can serve as a guiding support in the obstacles of translating theory to practical applications.

Latest Insights

Pharma Report PP Hero
August 30, 2023
AVAILABLE NOW | The Pharmaceutical Cannabis Report: 3rd Edition
Prohibition Partners are pleased to announce the publication of The Pharmaceutical Cannabis Report: 3rd Edition, which is now available to...
Pharma Report PP Hero
July 12, 2023
The Pharmaceutical Cannabis Report: 3rd Edition Now Available to Pre-Order
Prohibition Partners are pleased to announce that The Pharmaceutical Cannabis Report: 3rd Edition is now available to pre-order, prior to...
May 23, 2023
European Medical Cannabis: At a Glance
The European medical cannabis industry has seen steady growth over the past year and it is projected to reach over...
March 30, 2023
AVAILABLE NOW | The European Cannabis Report: 8th Edition
Prohibition Partners are proud to launch The European Cannabis Report: 8th Edition today.  The past year has been one of...

Events & Conferences

Business of Cannabis: New York

Location: New York, US

Date: 4 October, 2023

Business of Cannabis: New York will once again bring together the most influential leaders in policy, business, law and finance together to focus on the new capital of cannabis: New York. Join us at the New York Academy of Medicine.

Cannabis Europa London

Location: London, UK

Date: May, 2024

Join 1,500+ influential leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians — the crucial combination needed to drive the European cannabis industry and your business forward.

As Trusted By



on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.